Skip to main content

Table 2 Prices of Harvoni®, Epclusa®, and Daklinza® in Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, and the United Arab Emirates

From: Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study

Name of medicine

Price in Egypt for a 12 weeks

Price in Jordan for a 12 weeks

Price in Lebanon for a 12 weeks

Price in Morocco for a 12 weeks

Price in Saudi Arabia for a 12 weeks

Price in UAE for a 12 weeks

Harvoni® (Sofosbuvir + Ledipasvir)

1050 USD

67,000 USD

49,000 USD

1600 USD

66,450

USD

74,000 USD

Epclusa® (Sofosbuvir + Velpatasvir)

*432 USD

38,840 USD

34,380 USD

1900 USD

37,700 USD

69,250 USD

Daklinza® (Daclatasvir)

1527 USD

35,470 USD

NA

NA

33,252

USD

NA

  1. *Epclusa® is not registered in Egypt, the generic of it is produced by a local company